Blood microRNAs as markers of obstructive sleep apnea
Studies microRNAs in blood to spot obstructive sleep apnea and track treatment.
Key facts
- Who runs it
- University of Pennsylvania
- Where
- Columbus and Philadelphia, United StatesSee the 2 sitesAlso in 1 other country, 1 site
- Trial code
- Registry title
- MicroRNAs as Biomarkers for Obstructive Sleep Apnea
- Status
- Recruiting
- People taking part
- 500 people, planned
- Started
- 1 Apr 2024
- Expected to end
- 30 Apr 2028
- Type of study
- Observational, 2 groups
- Treatments tested
- Positive Airway Pressure
- Record updated
- 3 August 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with moderate to severe obstructive sleep apnea (breathing stops during sleep) who are willing to use PAP therapy. It is also looking for adults without sleep apnea as a comparison group.
- Age
- 18-75 years
- Sex
- All
- Disease stage
- People with sleep apnea need moderate to severe obstructive sleep apnea, meaning AHI ≥15 events/hour. People in the comparison group must have no sleep apnea, meaning AHI <5 events/hour.
- Earlier treatment
- People with sleep apnea cannot join if they already use PAP or another sleep apnea treatment. They must be willing to start PAP therapy.
Main reasons for not taking part
- Home oxygen therapy, or pregnancy
- Kidney disease (Stage 5) needing dialysis, a kidney transplant, or any organ transplant
- Sleeping less than 5 hours per night on work nights, or working night shifts now
- For people with sleep apnea: mostly central sleep apnea, or Cheyne-Stokes breathing in the sleep study
- For people with sleep apnea: changes to blood pressure medicines in the last 3 months
The registry criteria, word for word
Show all 21 criteriaShow less
Who can take part
- age 18-75 years
- moderate-severe OSA (defined as AHI ≥15 events/hour)
- willing to accept PAP therapy
- age 18-75 years
- no OSA (defined as AHI <5 events/hour)
Who cannot take part
- home oxygen therapy
- recent changes (within 3 months) to BP medications among those who are on these medications
- organ transplantation
- home oxygen therapy
- organ transplantation
- clinical history of chronic kidney disease (Stage 5) requiring dialysis, or renal transplant
- clinical history of chronic kidney disease (Stage 5) requiring dialysis, or renal transplant
- current use of PAP or other OSA treatments
- presence of Cheyne-Stokes Respiration (CSR) in sleep study
- predominantly central sleep apnea (AHI≥15 events/hour, with >50% central events)
- pregnancy
- self-reported sleep duration less than 5 hours per night on weeknights (work nights)
- current night shift work
- pregnancy
- self-reported sleep duration less than 5 hours per night on weeknights (work nights)
- current night shift work
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Where in United States
Also in 1 other country, 1 site
- The Ohio State University - Martha Morehouse Medical Pavilion, Suite 2600Columbus, United StatesContact: Ulysses J Magalang, MDTaking people
- University of PennsylvaniaPhiladelphia, United StatesContact: Colleen M Walsh, MSTaking people
About the trial
What the trial wants to find out
Although obstructive sleep apnea (OSA) is a common disorder, there are no blood biomarkers for identification and management of these patients. This project will study microRNAs in order to develop and validate blood biomarkers that are specific to OSA, useful for identification of cases with OSA, reflective of efficacy of therapy, and able to predict blood pressure response to treatment of OSA.
The 2 groups in the trial
- Cases
Moderate-severe OSA (defined as AHI ≥15 events/hour)
Treatment: Positive Airway Pressure
- Controls
No OSA (defined as AHI \<5 events/hour)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- MicroRNAs as Biomarkers for Obstructive Sleep Apnea
- Plain-language title
- Blood microRNAs as markers of obstructive sleep apneaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT06189755, who can take part
- Record updated
- 3 August 2026